Talphera (TLPH) Gains from Investment Securities (2024 - 2026)
Talphera (TLPH) posted quarterly Gains from Investment Securities of -$1.2 million for Q1 2026, down 575.69% year-over-year from $257099.9 in Q1 2025, and down 575.69% quarter-over-quarter from -$181000.0 in Q1 2025.
Talphera (TLPH) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Talphera's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 560,000.00 |
| Jun 30, 2026 | 560,000.00 |
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2025 | -181,000.00 |
| Mar 31, 2025 | -181,000.00 |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |